Wikipedia -WSS

Wikipedia

author：leisure time 2025-08-11 11:45:35 - browse：5838

Andrew Trister, an oncologist and veteran of big technology companies and research, is Verily's new chief scientific officer.

As Verily aims to get on track, the Alphabet life science company has hired Andrew Trister, an oncologist and veteran of big technology companies and research, as its new chief scientific officer.

Trister will lead Verily’s population health initiatives, including public health solutions like the company’s ongoing work to combat disease-carrying mosquito populations and a program that helps wastewater treatment plants monitor for pathogens. He will also consult across Verily’s diverse projects.

Trister’s focus on public health will build on his recent role as a deputy director at the Bill and Melinda Gates Foundation, where he led digital health, including a project to build tech infrastructure to help with malaria testing. Trister also led the foundation’s Covid-19 response. In 2016, he was an early health hire at Apple. There, he worked on programs like a heart health study with Janssen, an app to promote healthy habits with Aetna, and research into digital biomarkers for Alzheimer’s disease with Eli Lilly and Evidation.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： How to ethically and practically extend health care to all

WSS

BMS, looking to build heart drug business, turns to AI for diagnosis

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

Indictment alleges Trump's ex

'Null' research findings aren't empty of meaning. Let's publish them

Maui wildfire now ranks as the fifth

Florida officials tell state schools to teach AP Psychology 'in its entirety'

hotspot

Wikipedia

focus

Heart attack and stroke risk calculators need revising

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

Anesthesiologist group: stop taking Ozempic before surgery

Physicians aren't 'burning out.' They're suffering from moral injury

Alkermes shareholders re

FDA approves Sage Therapeutics’ rapid

Medicare details structure of new drug price negotiation program

Group behind ProMed defends move to subscription

BioMarin wins approval for gene therapy to treat hemophilia A

'Null' research findings aren't empty of meaning. Let's publish them

leisure time

Timeline: How the deadly wildfires took over Maui day by day

It costs an awful lot of money to give away a kidney

It costs an awful lot of money to give away a kidney

2 officers injured in shooting in Orlando, police say

Alnylam reports growth in sales of rare disease treatments

Patients, digital health players weigh in on FTC's data privacy plan

explore

Wikipedia

explore

hotspot